These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8320163)

  • 1. Strong inhibition of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole-induced mutagenesis and hepatocarcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone.
    Hirose M; Akagi K; Hasegawa R; Satoh T; Nihro Y; Miki T; Sugimura T; Ito N
    Jpn J Cancer Res; 1993 May; 84(5):481-4. PubMed ID: 8320163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Hirose M; Hasegawa R; Kimura J; Akagi K; Yoshida Y; Tanaka H; Miki T; Satoh T; Wakabayashi K; Ito N
    Carcinogenesis; 1995 Dec; 16(12):3049-55. PubMed ID: 8603484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1).
    Hirose M; Iwata S; Ito E; Nihro Y; Takahashi S; Mizoguchi Y; Miki T; Satoh T; Ito N; Shirai T
    Carcinogenesis; 1995 Sep; 16(9):2227-32. PubMed ID: 7554080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments.
    Hirose M; Futakuchi M; Tanaka H; Orita SI; Ito T; Miki T; Shirai T
    Eur J Cancer Prev; 1998 Feb; 7(1):61-7. PubMed ID: 9511852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis.
    Hirose M; Takahashi S; Ogawa K; Futakuchi M; Shirai T
    Food Chem Toxicol; 1999; 37(9-10):985-92. PubMed ID: 10541455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention by synthetic phenolic antioxidants of 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)- or activated MeIQx-induced mutagenesis and MeIQx-induced rat hepatocarcinogenesis, and role of antioxidant activity in the prevention of carcinogenesis.
    Hirose M; Ito T; Takahashi S; Ozaki M; Ogiso T; Nihro Y; Miki T; Shirai T
    Eur J Cancer Prev; 1998 Jun; 7(3):233-41. PubMed ID: 9696932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
    Futakuchi M; Hirose M; Miki T; Tanaka H; Ozaki M; Shirai T
    Eur J Cancer Prev; 1998 Apr; 7(2):153-9. PubMed ID: 9818778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats.
    Hirose M; Akagi K; Hasegawa R; Yaono M; Satoh T; Hara Y; Wakabayashi K; Ito N
    Carcinogenesis; 1995 Feb; 16(2):217-21. PubMed ID: 7859351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats.
    Hirose M; Takahashi S; Ogawa K; Futakuchi M; Shirai T; Shibutani M; Uneyama C; Toyoda K; Iwata H
    Cancer Lett; 1999 Sep; 143(2):173-8. PubMed ID: 10503899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone or ascorbic acid on carcinogenesis induced by administration of aminopyrine and sodium nitrite in a rat multi-organ carcinogenesis model.
    Yada H; Hirose M; Tamano S; Kawabe M; Sano M; Takahashi S; Futakuchi M; Miki T; Shirai T
    Jpn J Cancer Res; 2002 Dec; 93(12):1299-307. PubMed ID: 12495469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage and organ dependent effects of 1-O-hexyl-2,3,5-trimethylhydroquinone, ascorbic acid derivatives, n-heptadecane-8-10-dione and phenylethyl isothiocyanate in a rat multiorgan carcinogenesis model.
    Ogawa K; Futakuchi M; Hirose M; Boonyaphiphat P; Mizoguchi Y; Miki T; Shirai T
    Int J Cancer; 1998 Jun; 76(6):851-6. PubMed ID: 9626352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose dependence of 1-O-hexyl-2,3,5-trimethylhydroquinone promotion of forestomach carcinogenesis in rats pretreated with N-ethylnitrosourethane.
    Mizoguchi Y; Hirose M; Yamaguchi T; Boonyaphiphat P; Miki T; Shirai T
    Jpn J Cancer Res; 1998 May; 89(5):475-80. PubMed ID: 9685849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of chlorophyllin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats.
    Sugie S; Okamoto K; Makita H; Ohnishi M; Kawamori T; Watanabe T; Tanaka T; Mori H
    Jpn J Cancer Res; 1996 Oct; 87(10):1045-51. PubMed ID: 8957062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
    Sakata K; Hara A; Hirose Y; Yamada Y; Kuno T; Katayama M; Yoshida K; Zheng Q; Murakami A; Ohigashi H; Ikemoto K; Koshimizu K; Tanaka T; Mori H
    Oncology; 2004; 66(3):244-52. PubMed ID: 15218316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-methylcysteine and cysteine are inhibitors of induction of glutathione S-transferase placental form-positive foci during initiation and promotion phases of rat hepatocarcinogenesis.
    Takada N; Yano Y; Wanibuchi H; Otani S; Fukushima S
    Jpn J Cancer Res; 1997 May; 88(5):435-42. PubMed ID: 9247599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor induction in mice administered neonatally with 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole or 2-amino-dipyrido[1,2-a:3',2'-d]imidazole.
    Fujii K; Sakai A; Nomoto K; Nakamura K
    Cancer Lett; 1988 Jul; 41(1):75-80. PubMed ID: 3390804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity.
    Bear WL; Teel RW
    Anticancer Res; 2000; 20(5B):3609-14. PubMed ID: 11131669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in HCA-induced tumors.
    Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
    Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of chemical carcinogenesis by water-soluble organosulfur compounds.
    Fukushima S; Takada N; Wanibuchi H; Hori T; Min W; Ogawa M
    J Nutr; 2001 Mar; 131(3s):1049S-53S. PubMed ID: 11238814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
    Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
    Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.